These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. CSF levels of DJ-1 and tau distinguish MSA patients from PD patients and controls. Herbert MK; Eeftens JM; Aerts MB; Esselink RA; Bloem BR; Kuiperij HB; Verbeek MM Parkinsonism Relat Disord; 2014 Jan; 20(1):112-5. PubMed ID: 24075122 [TBL] [Abstract][Full Text] [Related]
11. Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease. Shi M; Zabetian CP; Hancock AM; Ginghina C; Hong Z; Yearout D; Chung KA; Quinn JF; Peskind ER; Galasko D; Jankovic J; Leverenz JB; Zhang J Neurosci Lett; 2010 Aug; 480(1):78-82. PubMed ID: 20540987 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic biomarkers for Parkinson's disease: focus on α-synuclein in cerebrospinal fluid. Kalia LV Parkinsonism Relat Disord; 2019 Feb; 59():21-25. PubMed ID: 30466800 [TBL] [Abstract][Full Text] [Related]
13. Discovery, validation and optimization of cerebrospinal fluid biomarkers for use in Parkinson's disease. Farotti L; Paciotti S; Tasegian A; Eusebi P; Parnetti L Expert Rev Mol Diagn; 2017 Aug; 17(8):771-780. PubMed ID: 28604235 [TBL] [Abstract][Full Text] [Related]
14. Increased level of DJ-1 in the cerebrospinal fluids of sporadic Parkinson's disease. Waragai M; Wei J; Fujita M; Nakai M; Ho GJ; Masliah E; Akatsu H; Yamada T; Hashimoto M Biochem Biophys Res Commun; 2006 Jul; 345(3):967-72. PubMed ID: 16707095 [TBL] [Abstract][Full Text] [Related]
15. The role of biomarkers and imaging in Parkinson's disease. Algarni MA; Stoessl AJ Expert Rev Neurother; 2016; 16(2):187-203. PubMed ID: 26829357 [TBL] [Abstract][Full Text] [Related]
16. Value of cerebrospinal fluid α-synuclein species as biomarker in Parkinson's diagnosis and prognosis. Parnetti L; Cicognola C; Eusebi P; Chiasserini D Biomark Med; 2016; 10(1):35-49. PubMed ID: 26643452 [TBL] [Abstract][Full Text] [Related]
17. Salivary α-synuclein and DJ-1: potential biomarkers for Parkinson's disease. Devic I; Hwang H; Edgar JS; Izutsu K; Presland R; Pan C; Goodlett DR; Wang Y; Armaly J; Tumas V; Zabetian CP; Leverenz JB; Shi M; Zhang J Brain; 2011 Jul; 134(Pt 7):e178. PubMed ID: 21349902 [No Abstract] [Full Text] [Related]
18. The DJ-1 concentration in cerebrospinal fluid does not differentiate among Parkinsonian syndromes. Salvesen L; Bech S; Lokkegaard A; Hjermind LE; Nielsen JE; Pakkenberg B; Tanassi JT; Heegaard NH; Winge K Parkinsonism Relat Disord; 2012 Aug; 18(7):899-901. PubMed ID: 22503539 [No Abstract] [Full Text] [Related]
19. A First Tetraplex Assay for the Simultaneous Quantification of Total α-Synuclein, Tau, β-Amyloid42 and DJ-1 in Human Cerebrospinal Fluid. Kruse N; Schlossmacher MG; Schulz-Schaeffer WJ; Vanmechelen E; Vanderstichele H; El-Agnaf OM; Mollenhauer B PLoS One; 2016; 11(4):e0153564. PubMed ID: 27116005 [TBL] [Abstract][Full Text] [Related]
20. Cheek cell-derived α-synuclein and DJ-1 do not differentiate Parkinson's disease from control. Stewart T; Sui YT; Gonzalez-Cuyar LF; Wong DT; Akin DM; Tumas V; Aasly J; Ashmore E; Aro P; Ginghina C; Korff A; Zabetian CP; Leverenz JB; Shi M; Zhang J Neurobiol Aging; 2014 Feb; 35(2):418-20. PubMed ID: 24041968 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]